#ESCMIDGlobal2026 To view or add a comment, sign in 70,533 followers Sinai Health researchers have found that semaglutide, the active ingredient in popular GLP-1 medicines, acts directly on the liver to reduce inflammation and scarring, independently of weight loss
Data collection Demographic characteristics, anthropometric measures, comorbid conditions, duration of diabetes and renal disease, dialysis status and modality, and concomitant glucose-lowering therapies were extracted from the electronic medical record system
Most melanotic schwannomas are clinically benign tumors [4]
For all other patients, periodic thyroid examination and awareness of thyroid-related symptoms (neck mass, dysphagia, persistent hoarseness) is prudent during long-term therapy
Image analysis revealed increased cellularity in GHK-Cu treated samples at the intra-articular mid-substance at 6 weeks, particularly with the higher dose, though this difference was not statistically significant [1]
Endogenous brainstem GLP-1 responding to stress is not the same system as a synthetic peptide delivered subcutaneously at therapeutic doses
